BraveNet Integrative Medicine Descriptive Study

NCT ID: NCT00636779

Last Updated: 2011-06-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

4340 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-03-31

Study Completion Date

2011-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The Bravewell Integrative Medicine Research Network (BraveNet) is a newly formed practice-based research network of nine leading integrative medicine centers around the U.S. collaborating in clinical outcomes research to increase the knowledge and evidence-base of integrative medicine.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Specific Aims of BraveNet:

1. Demonstrate feasibility for the nine sites of BraveNet to coordinate in specifying data elements, developing and implementing smooth data collection procedures, analyzing the data, publishing and disseminating the results through scientific conferences and journals.
2. Describe the patients seeking care at Integrative Medicine centers, in terms of:

1. demographics, presenting symptoms, health conditions, type of care sought, and expectations for treatment;
2. quality of life, mood, stress; and
3. lifestyle factors.
3. Explore potential patterns within the sample \[e.g., do the survey scores vary by demographics, by condition, by type patient (new vs return), by type of help sought, etc.\].
4. Utilize above data as pilot data for future studies and funding opportunities.

Up to five hundred eligible patients seen at each of the nine participating Centers will be approached (by mail, phone, at the time of their visit, etc.) and invited to consent to the paper and pencil study. The patient survey will clearly state that participation is voluntary with a written consent to participate on the front. Individual practices will report the response rate in order to monitor the potential effect of volunteer bias. Participant completion of questionnaires should take 15 to 30 minutes, and should be completed within 2 weeks of the patient visit., The corresponding provider form will be completed by the provider/research staff within 5 days of the visit.

Measures:

1. Baseline Questionnaires - Demographics and reason for visit
2. Quality of Life. The SF-12 (Short Form 12)
3. Mood (Depression). The Center for Epidemiologic Studies Depression Scale (CES-D)
4. Stress. The Perceived Stress Scale (PSS)
5. Visual Analog Scales (VAS). Four self-report VASs will be used to measure aspects of pain, fatigue and restfulness of sleep.
6. Provider Form. Providers/ Research Staff will complete this form to indicate the type of provider seen, the CPT codes used to describe/bill for the service, the services provided, and the provider's assessment of current medical conditions/co-morbidities.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Up to five hundred eligible patients seen at each of the nine participating Integrative Medicine Centers will be approached (by mail, phone, at the time of their visit, etc.) and invited to consent to the paper and pencil study.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects will be eligible for inclusion in this study only if all of the following criteria apply:

1. Age: At least 18 years of age.
2. Patient Status: Participants are eligible if seen individually by any type of clinician on the day of the visit.
3. English or Spanish Literacy: Ability to read and write English or Spanish as confirmed by the site personnel and ability to provide informed consent.

Exclusion Criteria

* Subjects will be excluded from this study if any of the following criteria apply:

1. Cognitive Impairment: A subject will not be eligible if he/she has a history of psychiatric disease, dementia, Alzheimer's disease, or other conditions which will limit the validity of providing informed consent to participate in the study.
2. Inability to read and write in English or Spanish.
3. Participating only in educational Center activities, not as a clinical patient.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The Bravewell Collaborative

OTHER

Sponsor Role collaborator

Alliance Institute for Integrative Medicine

OTHER

Sponsor Role collaborator

Allina Health System

OTHER

Sponsor Role collaborator

Scripps Center for Integrative Medicine

OTHER

Sponsor Role collaborator

University of California, San Francisco

OTHER

Sponsor Role collaborator

University of Maryland

OTHER

Sponsor Role collaborator

The Continuum Center for Health and Healing

UNKNOWN

Sponsor Role collaborator

Thomas Jefferson University

OTHER

Sponsor Role collaborator

Venice Family Clinic

OTHER

Sponsor Role collaborator

Duke University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Bravewell Integrative Medicine Research Network (BraveNet)

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Rowena Dolor, MD

Role: PRINCIPAL_INVESTIGATOR

Duke Clinical Research Institute

Ruth Wolever, PhD

Role: PRINCIPAL_INVESTIGATOR

Duke Integrative Medicine Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Scripps Center for Integrative Medicine

La Jolla, California, United States

Site Status

Osher Center for Integrative Medicine

San Francisco, California, United States

Site Status

Venice Family Clinic

Santa Monica, California, United States

Site Status

University of Maryland Center for Integrative Medicine

Baltimore, Maryland, United States

Site Status

Penny George Institute for Health and Healing

Minneapolis, Minnesota, United States

Site Status

Duke Integrative Medicine

Durham, North Carolina, United States

Site Status

Alliance Center for Integrative Medicine

Cincinnati, Ohio, United States

Site Status

Jefferson-Myrna Brind Center of Integrative Medicine

Philadelphia, Pennsylvania, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Pro00006850

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

AIMS Medical Outcomes Study
NCT04512755 RECRUITING
Multi-Institutional IMPACT Validation
NCT06850857 ENROLLING_BY_INVITATION
Inflammatory Response to OMT
NCT06820684 COMPLETED NA
Longitudinal Innate Immunity and Aging Study
NCT03944603 ACTIVE_NOT_RECRUITING